SHAMIR NACHUM 4

What Happened

• Shamir Nachum, a director of MediWound Ltd. (MDWD), made two open-market purchases on 2026-06-03 totaling 6,000 ordinary shares. He bought 175 shares at $13.97 (reported value $2,446) and 5,825 shares at $14.00 (reported value $81,550), for a combined reported value of $83,996. This was a purchase transaction (often viewed positively by investors, though it does not prove future performance).

Key Details

• Transaction dates and prices:
  • 2026-06-03 — 175 shares @ $13.97 (reported $2,446)
  • 2026-06-03 — 5,825 shares @ $14.00 (reported $81,550)
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes:
  • F1: Some reported ordinary shares consist of RSUs granted Mar 4, 2026 that vest 100% on the one‑year anniversary.
  • F2: Certain rows were informational; no transactions were effected for those securities.
  • F3: Options reported were granted Mar 4, 2026 and vest 100% on the one‑year anniversary.
• Timeliness: Filing was made 2026-06-04 for transactions on 2026-06-03 (filed the next day), so no late-filing indication in the provided data.
• Other: Exhibit 24.1 (Power of Attorney) included in the filing.

Context

• The filing shows open-market purchases, not option exercises or immediate sales. The footnotes indicate separate RSU and option grants from March 4, 2026 that vest in one year; those are grants/holdings information rather than the June 3 purchases. Purchases by insiders can be of interest to retail investors as one data point, but they do not guarantee company performance.